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Alcoholic liver disease (ALD) is a major cause of chronic liver disease and a growing health concern in
theworld. While the pathogenesis of ALD is poorly characterized key players identiﬁed in experimental
models and patients, such as perturbations in mitochondrial structure and function, selective loss of
antioxidant defense and susceptibility to inﬂammatory cytokines, contribute to ALD progression. Both
oxidative stress and mitochondrial dysfunction compromise essential cellular functions and energy
generation and hence are important pathogenic mechanisms of ALD. An important process mediating the
mitochondrial disruption induced by alcohol intake is the trafﬁcking of cholesterol to mitochondria,
mediated by acid sphingomyelinase-induced endoplasmic reticulum stress, which contributes to increased
cholesterol synthesis and StARD1upregulation. Mitochondrial cholesterol accumulation not only sensitizes
to oxidative stress but it can contribute to the metabolic reprogramming in ALD, manifested by activation
of the hypoxia inducible transcription factor 1 and stimulation of glycolysis and lactate secretion. Thus, a
better understanding of the mechanisms underlying alcohol-mediated mitochondrial impairment and
oxidative stress may lead to the identiﬁcation of novel treatments for ALD. The present review brieﬂy
summarizes current knowledge on the cellular and molecular mechanisms contributing to alcohol-
induced mitochondrial dysfunction and cholesterol accumulation and provides insights for potential
therapeutic targets in ALD.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Alcoholic liver disease (ALD) encompasses a spectrum of liver
alterations ranging from simple steatosis to more advanced stages
such as alcoholic steatohepatitis (ASH), cirrhosis and hepatocel-
lular carcinoma (HCC) [1]. Alcoholic hepatitis (AH), ﬁrst described
in 1961, is a separate clinical entity characterized by acuteB.V. This is an open access article u
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,inﬂammation, severe jaundice, anorexia, abdominal pain, nausea
and vomiting, and exhibits a high-mortality rate [2]. The mechan-
isms underlying the transition from steatosis to ASH remain
incompletely understood and include interactions between alco-
hol with genetic, environmental and nutritional factors [3–5].
Moreover, the dose, duration and type of alcohol consumption as
well as drinking patterns and the presence of associated risk
factors, including obesity, iron overload and concomitant infection
with viral hepatitis can contribute to the progression of ALD.
Chronic ASH is associated with a number of histologic changes,
including the presence of Mallory’s hyaline, megamitochondria,
nuclear vacuolization, lobular inﬂammation, or perivenular and
perisinusoidal ﬁbrosis [3]. ALD, one of the oldest forms of liver
injury known to humankind, is still a leading cause of liver-related
morbidity and mortality and a major health issue in the world
[6,7]. Up to 50% of cases of end-stage liver disease have alcohol as a
major etiologic factor [6], which reﬂects the lack of effective
therapies for the treatment of ALD due to our incomplete under-
standing of the basic mechanisms underlying alcohol-mediated
cell damage [1,3,8]. Nevertheless, there have been importantnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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gression of the disease from its initial stage of steatosis [9]. Cellular
redox imbalance, exempliﬁed by abnormal NADþ/NADH ratio,
endoplasmic reticulum (ER) stress and oxidative stress, impaired
autophagy, and mitochondrial dysfunction are considered impor-
tant contributory factors for ALD. The superimposition of these
mechanisms with disruption of methionine metabolism and
altered phosphatidylcholine homeostasis can accelerate liver de-
terioration and ALD progression [10]. Given the role of mitochon-
dria in energy production, metabolism, cell death and generation
of reactive oxygen/nitrogen species (ROS/RNS), alcohol-induced
mitochondrial dysfunction is recognized as a key mechanism of
ALD and is a hallmark of the disease. Here, we will brieﬂy cover
some of the most relevant aspects of mitochondrial dysfunction
caused by alcohol consumption, particularly the accumulation of
cholesterol in mitochondria, and its impact in oxidative stress and
the underlying mechanisms, which may provide novel therapeutic
opportunities for the treatment of ALD.Mitochondrial alterations in ALD
Mitochondria are intracellular organelles with a double mem-
brane that function as the cell's powerplants by generating the
energy required for vital metabolic reactions and cellular home-
ostasis. Indispensable for this crucial role of mitochondria is the
presence of the mitochondrial respiratory chain (MRC) and the
oxidative phosphorylation (OXPHOS) that transduce electron
transport into energy generation in the form of ATP upon ADP
phosphorylation. The liver is one of the richest organs in terms of
number and density of mitochondria; each hepatocyte can contain
about 800 mitochondria [11]. Mitochondria provide the energy
required for multiple cell functions by transforming nutrient inﬂux
into ATP. This process is associated with the generation of ROS/RNS
due to the leakage of electrons from the MRC to molecular oxygen
[12,13]. While in vitro evidence indicated that between 0.12–2% of
the oxygen consumed in OXPHOS is used to generate superoxide
anion, this estimation cannot be extrapolated in vivo [14]. In
particular, hepatic mitochondria are recognized as a major source
of ROS whose overproduction can contribute to ALD pathogenesis
[15]. Under physiological conditions, most of the ROS generated by
the MRC are detoxiﬁed by mitochondrial antioxidant defenses,
primarily SOD2/MnSOD, which converts superoxide anion to
hydrogen peroxide; hydrogen peroxide is subsequently detoxiﬁed
by peroxiredoxin-III (Prx-III)/thioredoxin-2 (Trx-2) and the GSH
redox cycle. Undetoxiﬁed ROS, particularly hydrogen peroxide, can
diffuse out of mitochondria where they function as signaling
molecules [15–18]. Accumulation of superoxide anion favors its
interaction with nitric oxide to form the potent oxidant peroxyni-
trite that can target mitochondrial components; hydrogen perox-
ide accumulation contributes to oxidant dependent cell death
upon formation of potent free radicals in the presence of metals
in the Fenton reaction [15]. Mitochondria are also involved in key
cellular functions such as Ca2þ homeostasis, heme biosynthesis,
steroid hormone biosynthesis, nutrient metabolism, removal of
ammonia, and activation of signaling pathways and cell death
[15,19,20]. In this regard, emerging evidence indicates that mito-
chondria are intimately involved in cell signaling pathways, ser-
ving as platforms and effectors in multiple processes such as
innate immunity, autophagy and cell death [21]. Emerging data
also support a crucial, role for mitochondrial dynamics and
physical interaction between mitochondria and the ER in signaling
pathways and in the maintenance of ER and mitochondria home-
ostasis [21].
Mitochondrial dysfunction is frequently described as an early
event in several chronic pathological conditions [15,18,22]. In theliver, chronic diseases including ASH and nonalcoholic steatohe-
patitis (NASH), viral hepatitis, drug-induced hepatotoxicity and
HCC, are characterized by mitochondrial dysfunction [15,18].
However, a growing body of evidence has also shown that injured
cells with damaged mitochondria can develop cytoprotective
mechanisms that ensure cellular energy homeostasis and limit
cell death, including mitophagy, a specialized form of autophagy
that removes damaged or dysfunctional mitochondria [23]. In
addition, mitochondria are unique because they are the only
cellular organelle that contains its own DNA encoding 13 poly-
peptides of the OXPHOS and MRC. Alterations in mitochondrial
morphology and function are a hallmark of ALD. Early observa-
tions in alcoholic patients described the presence of megamito-
chondria that was associated with a milder form of ALD, lower
incidence of cirrhosis and fewer complications with a good long-
term hepatocellular survival [24,25]. Moreover, a common dele-
tion of mitochondrial DNA is frequently observed in alcoholic
patients with microvesicular steatosis [26]. Studies in experimen-
tal models indicated a wide range of mitochondrial functional
alterations [19]. Early studies in the 70s described mitochondrial
damage as an early and characteristic feature of ALD in experi-
mental models in rat liver that were conﬁrmed in subsequent
investigations [27]. For instance, rats fed alcohol orally (Lieber–
DeCarli liquid diet) exhibit lower mitochondrial respiration (state
III) rates and lower respiratory control ratio (state III/state IV) in
isolated liver mitochondria [28–30]. Also, chronic alcohol intake
has been shown to impair hepatic mitochondrial OXPHOS (e.g.
subunits of complexes I–V) by suppressing the synthesis of protein
subunits encoded by mitochondrial DNA and decreasing mito-
chondrial protein synthesis by interfering with mitochondrial
ribosomes [31]. The lower capacity of oxidative phosphorylation
results in the accumulation of reduced respiratory carriers in
complexes I and III, which stimulates superoxide anion generation
[19]. A proteomic approach in rats fed alcohol reported the
differential expression of hepatic mitochondrial proteins, 13 of
which increased while 30 exhibited decreased by alcohol [32]. In
contrast to alcohol feeding in rats, a recent study in mice fed
alcohol via intragastric or oral administration highlights the
dynamic changes in mitochondrial function and morphology
caused by alcohol [33]. These ﬁndings include: 1) increased state
III respiration in isolated liver mitochondria, associated with
increased levels of complexes I, IV, and V incorporated into the
MRC; 2) increased mitochondrial NADþ and NADH levels (2-fold),
with no change in the redox status; 3) alteration in mitochondrial
morphology, with increased numbers of elongated mitochondria;
and 4) increased hepatic PGC-1α expression, suggesting enhanced
mitochondrial biogenesis. Interestingly, these mitochondrial per-
turbations in mice correlated with increased liver injury induced
by alcohol feeding, which is more pronounced in the intragastric
than in the oral model. Moreover, as mitochondria are the major
consumers of molecular oxygen, the stimulation of mitochondrial
respiration in mice fed alcohol may contribute to the characteristic
hypermetabolic state and subsequent hypoxia and liver injury,
which are preferentially seen in pericentral hepatocytes. The
mechanisms underlying the contrast between these ﬁndings in
mice, characterized by increased mitochondrial respiration, and
rats with decreased mitochondrial respiration, remain to be fully
understood. However, as alcohol feeding induces lower injury in
rats than mice, the decreased mitochondrial respiration capacity
following alcohol feeding may be considered a protective mechan-
ism against ALD. These ﬁndings suggest that the increased
mitochondrial respiration induced by alcohol in mice may reﬂect
an adaptation for a more efﬁcient alcohol metabolism, which
requires steady supply of NADþ equivalents. Whether the in-
creased mitochondrial respiration is causally linked to the stimu-
lation of alcohol metabolism via alcohol dehydrogenase (ADH) and
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from NADH remains to be established. Thus, the impact and
mechanisms of the stimulation of mitochondrial respiration in
alcohol-fed mice deserves further investigation.ROS generation in ALD: source, defense and consequences
The oxidative metabolism of ethanol in the liver is an impor-
tant source of mitochondrial-derived ROS, which induce oxidative
stress and cell injury in ALD [7]. Alcohol is primarily metabolized
by the concerted action of ADH in the cytosol and the low Km
ALDH in the mitochondria. Both enzymes are kinetically limited by
the NADþ availability, which is reduced to NADH upon oxidation
of alcohol to acetaldehyde and acetate. The regeneration of NADH
to NADþ which occurs in the MRC ensures not only continued
alcohol oxidation but constitutes an important source of ROS
generation [34]. In addition to ADH/ALDH alcohol is also metabo-
lized by CYP2E1, the predominant cytochrome P450 isoform that
oxidizes ethanol to acetaldehyde. CYP2E1 is loosely coupled and
prone to radical formation, including hydroxyethyl radicals [34].
Although the Km of ADH for alcohol is lower than the Km of CYP2E1
for alcohol, the latter pathway is inducible by alcohol and hence
stands as a major contributor for the oxidative metabolism of
alcohol and hence for ROS formation. This pathway is active
mostly in the endoplasmic reticulum (ER), although a mitochon-
drial CYP2E1 isoform has been described [35,36]. CYP2E1 meta-
bolizes a number of small molecules of toxicological interest
including ethanol, acetaminophen, halothane, carbon tetrachloride
and carcinogens such as nitrosamines [37]. It is well established
that CYP2E1 causes oxidative stress through the production of
ROS/RNS in vivo [38] and in vitro [39–41]. Interestingly, ethanol
exposure increases the expression of CYP2E1 both in the ER and
mitochondria [35]. There is evidence that mitochondrial CYP2E1
can induce deleterious effects. For instance, expression of a 40-kDa
mitochondrial CYP2E1 favored oxidative stress and cytotoxicity in
GSH-depleted HepG2 cells [42]. Moreover, by introducing speciﬁc
mutations in the N-terminal 40-amino acid sequence of the rat
CYP2E1 that preferentially target CYP2E1 to ER or mitochondria,
Bansal et al. reported a higher rate of GSH depletion in cells
expressing mutant CYP2E1 targeted to mitochondria compared with
cells expressing mutant CYP2E1 targeted to ER [43]. Finally, full-
length CYP2E1 found in liver mitochondria from streptozotocin
diabetic rats generated signiﬁcant amount of ROS within these
organelles [44]. Thus, alcohol oxidation by the ADH/ALDH system
and the alcohol-inducible mitochondrial CYP2E1 are important
sources of mitochondrial ROS generation in ALD.
As indicated above, the transfer of electrons from MRC to
oxygen generates superoxide anion. The predominant defense
against the accumulation of mitochondrial superoxide anion is
MnSOD. MnSOD is essential for life, as illustrated by the neonatal
lethality of mice deﬁcient in MnSOD [45]. However, the role of
alcohol on MnSOD regulation is controversial [46–48]. Homozy-
gous mutations in the mitochondrial targeting sequence of
MnSOD, which are associated with increased mitochondrial loca-
lization and activity, is a risk factor for progressive disease in
patients with ALD [49]. These ﬁndings may seem intriguing as
elimination of superoxide anion by MnSOD might be expected to
protect against ALD. The scavenging of superoxide by MnSOD gen-
erates hydrogen peroxide, and MnSOD activation in ALD may exceed
the capacity to eliminate hydrogen peroxide, which is detoxiﬁed by
the Prx-III/Trx-2 and the GSH redox cycle. A vital component of
this redox cycle is mitochondrial GSH (mGSH), which ensures the
elimination of hydrogen peroxide by GSH peroxidases (Gpx)
[15,17]. Both antioxidant systems are of relevance in hydrogen
peroxide elimination and protection against oxidative stress. Forinstance, deletion of the mitochondrial targeted Gpx4 is embryo-
nic lethal [50], and kinetic competition analysis reported that an
important amount of hydrogen peroxide generated in mitochon-
dria targets PrxIII [51]. While the relative importance of Prx-III/
Trx-2 vs mGSH/Gpx in protection and susceptibility to oxidant cell
death has not been speciﬁcally addressed, recent ﬁndings have
shown that selective mGSH depletion sensitized hepatocytes
against hydrogen peroxide accumulation induced by superoxide
scavenging with MnTBAP despite Prx-III/Trx-2 defense [52]. More-
over, depletion of mGSH results in Trx2 oxidation and impaired
Prx-III reactivation and mGSH depletion in hypercholesterolemic
pigs decreases the levels of the mitochondria-speciﬁc antioxidant
enzymes such as MnSOD, Trx2, and PrxIII [53,54]. Importantly, it
has been reported that alcohol consumption depletes mGSH
selectively [55–59], and this effect is rapidly reversed upon alcohol
withdrawal [60,61]. Furthermore, recent ﬁndings in rats fed with
an ethanol-polyunsaturated fatty acid diet conﬁrmed the deple-
tion of mGSH that preceded ASH development, effects that were
prevented by betaine treatment [62].
The depletion of mGSH by alcohol may be of relevance to ALD
progression. Not only mGSH depletion contributes to oxidative
stress, but mGSH determines the critical balance between mito-
chondrial antioxidant defenses necessary to ensure protection
against oxidative stress [52]. MnSOD overexpression aggravates
the deleterious effects of prolonged alcohol feeding on mitochon-
drial DNA in mice [63]. Alcohol-induced mGSH depletion sensi-
tizes hepatocytes to TNF-induced cell death [64]. The mechanism
of mGSH depletion-induced sensitization to TNF is independent of
NF-κB inactivation and involves mitochondrial ROS overproduc-
tion and cardiolipin peroxidation that determined mitochondrial
outer membrane restructuring and mitochondrial outer mem-
brane permeabilization [65]. Inﬂammation is an important feature
of progressive ALD, particularly ASH and AH. Recent ﬁndings have
reported increased production of IL-1β and inﬂammasome assem-
bly in mice fed alcohol [66], and mitochondrial ROS induce the
redistribution of NLRP3 and ASC to mitochondria/ER contact sites
and stimulate caspase 1-mediated IL-1β processing [67]. There-
fore, it is conceivable that mGSH depletion caused by alcohol
feeding may contribute to the inﬂammasome activation and hence
generation of IL-1β characteristic of ALD. Consistent with these
ﬁndings, we have observed that cholesterol feeding to mice
synergized with alcohol to cause ASH, inﬂammasome activation
and IL-1β production (Conde de la Rosa, manuscript in prepara-
tion). Besides ROS, recent ﬁndings have demonstrated a ROS
independent inﬂammasome activation involving the redistribu-
tion of cardiolipin from the inner to the outer mitochondrial
membrane [68]. Whether mGSH depletion caused by alcohol
contributes to cardiolipin-dependent inﬂammasome activation
and IL-1β deserves further investigation.Mitochondrial cholesterol and ALD: regulation of
mitochondrial GSH and metabolic reprogramming
The role of cholesterol in liver diseases has attracted increasing
attention in recent years and it is currently considered a key player
in ASH and NASH [69]. In particular, the trafﬁcking of cholesterol
to mitochondrial membranes sensitizes hepatocytes to TNF-
mediated steatohepatitis and cell death by promoting mGSH
depletion [70]. Indeed, cholesterol enrichment in isolated mito-
chondria impairs the mitochondrial transport of GSH resulting in
mGSH depletion (Fig. 1). The effect of cholesterol in the mitochon-
drial transport of GSH is dependent on the changes of mitochon-
drial membrane dynamics; however, this effect is selective for the
mGSH transport as other mitochondrial carriers are insensitive to
cholesterol loading [71]. The cholesterol/phospholipid molar ratio
Fig. 1. Regulation of mitochondrial GSH transport by mitochondrial cholesterol. (A) The transport of GSH to mitochondrial matrix via the mGSH carrier OGC is dependent on
membrane dynamics. Under physiological conditions the OGC carrier transports GSH into mitochondrial matrix by exchanging mitochondrial 2-oxoglutarate (2OG) by
cytosolic GSH. The mitochondrial GSH/Gpx and the PrxIII/Trx are key mitochondrial antioxidant defenses to control the generation of hydrogen peroxide, which is largely
formed from the dismutation of superoxide anion by MnSOD. Oxygen consumption in the mitochondrial respiratory chain (MCR) generates superoxide anion. (B) In alcohol
fed models cholesterol accumulates in the mitochondrial inner membrane, which impairs OGC carrier by the loss of membrane ﬂuidity resulting in the depletion of
mitochondrial GSH. Mitochondrial GSH depletion compromises the elimination of hydrogen peroxide via the GSH redox cycle and Gpx and contributes to ROS
overgeneration. Besides impairing the OGC carrier, mitochondrial cholesterol accumulation by alcohol can trigger lipotoxicity by activating JNK1 and contribute to the
metabolic alterations in ALD reﬂected by activation of HIF1a and glycolysis.
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the increase in membrane cholesterol disrupts lipid organization
and decreases the transition of liquid-ordered to liquid-disordered
phases of membranes [72]. This change in membrane packing
impacts in the activity of speciﬁc membrane proteins, such as the
mGSH carrier (see below). However, the mitochondrial transport
of S-adenosyl-L-methionine or the uptake of adenine nucleotide
via the adenine nucleotide translocator are insensitive to the
decrease in membrane ﬂuidity induced by cholesterol loading
[71,73]. Consequently, alcohol feeding caused mitochondrial cho-
lesterol accumulation and subsequent mGSH depletion by stimu-
lating the expression of the mitochondrial cholesterol carrier
StARD1 [74], whose regulation is discussed in the next section. The
accumulation of cholesterol to mitochondria has been recently
reported in rats fed ethanol along with polyunsaturated fatty acids
[62]. The impact of mitochondrial cholesterol accumulation in the
depletion of mGSH is not an exclusive feature of ASH as it has been
also reported in other contexts, including NASH and anthrax-
induced cell death [75,76].
At the molecular level, the effect of cholesterol in the regulation
of mGSH is mediated by the susceptibility of the 2-oxoglutarate
carrier (OGC) to perturbations in membrane dynamics. Functional
expression analyses in Xenopus laevis oocytes microinjected with
OGC cRNA showed enhanced transport of GSH in isolated mito-
chondria [77]. Moreover, cholesterol enrichment impairs the
transport kinetics of 2-oxoglutarate via the OGC by decreasing
mitochondrial membrane ﬂuidity. Restoration of membrane dy-
namics by the fatty acid analog A2C improves the activity of OGC
and mGSH transport despite cholesterol enrichment. In liver
mitochondria and HepG2 cells the transport of GSH exhibits two
kinetic components with high and low afﬁnity [78]. Mitochondrial
cholesterol accumulation in HepG2 cells induced by acetaldehyde
treatment increased the Michaelis constant for the high- and low-
afﬁnity components, with a greater impact on the former [79].
However, kinetic analyses of 2-oxoglutarate transport in rat livermitochondria exhibited a single Michaelis–Menten component
with kinetic parameters in the range of those reported previously
for kidney mitochondria and a Km close to the high Km of
mitochondrial GSH transport [77,80]. Overall, these ﬁndings sug-
gest that the OGC accounts for the low-afﬁnity high capacity of
GSH transport in liver mitochondria.
Besides depleting mGSH levels, mitochondrial cholesterol has
emerged as a key player in lipotoxicity. Recent studies in primary
mouse hepatocytes loaded with free cholesterol upon incubation
with LDL reported that mitochondrial cholesterol deposition
caused hepatocyte apoptosis and necrosis by activating JNK1
[81]. These effects were accompanied by mitochondrial membrane
pore transition, cytochrome c release, oxidative stress and ATP
depletion. Deletion of JNK1 and TLR4 protected against mitochon-
drial cholesterol lipotoxicity. Moreover, HMGB1 was released into
culture medium of wild type hepatocytes but not JNK1 / or
TLR4/ hepatocytes loaded with free cholesterol, while anti-
HMGB1 anti-serum prevented JNK activation and free cholesterol
lipotoxicity in wild type hepatocytes. Consistent with these ﬁnd-
ings, HMGB1 overexpression has been reported in patients with
ALD and HMGB1 plays a critical role in alcohol-induced liver injury
[82]. Whether mitochondrial cholesterol contributes to alcohol-
induced JNK activation and HMGB1 upregulation remains to be
determined. Moreover, mitochondrial cholesterol accumulation in
mouse hepatocytes has been recently shown to stabilize the
hypoxia inducible transcription factor 1α (HIF-1α) in normoxia
by a ROS dependent mechanism [83]. The impact of mitochondrial
cholesterol in the prevention of HIF-1α degradation was abolished
by the depletion of mitochondrial DNA. Although mGSH levels
were not examined in the preceding report, previous studies
demonstrated that mGSH levels determine the survival of hepa-
tocytes during hypoxia and that mGSH depletion stimulated
hypoxia-induced ROS generation [84,85]. Given the role of hypoxia
in alcohol induced steatosis and ALD [86], it is conceivable that
mitochondrial cholesterol-mediated ROS generation via mGSH
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Finally, stimulated mitochondrial cholesterol trafﬁcking by silen-
cing the endolysosomal proteins Niemann Pick type C proteins 1/2
(NPC1/2) stimulates lactate secretion and decreases glutamine-
dependent mitochondrial respiration and ATP transport across
mitochondrial membranes [87]. In line with these ﬁndings, alcohol
feeding in mice stimulates glycolysis and lactate secretion, sug-
gesting that alcohol induces a metabolic shift from mitochondrial
respiration to aerobic glycolysis [88]. Moreover, it is conceivable
that mitochondrial cholesterol accumulation by alcohol can con-
tribute to the mitochondrial dysfunction in ALD. For instance,
mitochondrial cholesterol loading due to NPC1 mutations impairs
the mitochondrial ATP synthase activity, which is restored upon
cholesterol extraction by cyclodextrin. These ﬁndings suggest that
alcohol-induced mitochondrial cholesterol accumulation may con-
tribute to mitochondrial dysfunction and the metabolic repro-
gramming caused by alcohol consumption, characterized by HIF-
1α stabilization and stimulated glycolysis (Fig. 1).Mechanisms of mitochondrial cholesterol regulation
in ALD: role of ER stress
Given the emerging role of mitochondrial cholesterol in the
regulation of mitochondrial function, membrane properties and
transport functions, uncovering the mechanisms underlying the
trafﬁcking of cholesterol to mitochondria may be of potential
relevance in ALD. The restricted mitochondrial cholesterol pool
plays important physiological roles, such as in steroidogenesis in
specialized tissues or bile acids synthesis in the liver. StARD1 is the
founding member of a family of lipid transporting proteins that
contain StAR-related lipid transfer (START) domains. StARD1 is an
outer mitochondrial membrane protein which was ﬁrst described
and best characterized in steroidogenic cells where it plays an
essential role in cholesterol transfer to the mitochondrial inner
membrane for metabolism by CYP11A1 to generate pregnenolone,
the precursor of steroids [89,90]. Despite similar features with
StARD1, other START members cannot replace StARD1 deﬁciency
as global StARD1 knockout mice dye within 10 days due to
adrenocortical lipoid hyperplasia [91]. StARD1 silencing decreases
mitochondrial cholesterol levels in HepG2 cells and stimulates
mitochondrial outer membrane permeabilization [92]. Moreover,Fig. 2. Role of ER stress in the regulation of StARD1. A fundamental mechanism in th
activation of ASMase generates ceramide, which in turn causes ER stress resulting in the a
in the ER and the three arms of the unfolded protein response that induce the transcript
ER stress by regulating ER Ca2þ homeostasis via SERCA remains to be determined. Bes
regulate StARD1 activity and hence may contribute to the regulation of mitochondrial
3 arms of the UPR in the transcriptional regulation of StARD1 and the putative StARD1alcohol feeding upregulates liver StARD1 mRNA levels with similar
results observed in patients with AH [74]. Interestingly, alcohol
feeding, however, does not inﬂuence the expression of StARD3
(also known as MLN64), suggesting this particular member of the
StART family plays a minor role in alcohol-induced mitochondrial
cholesterol accumulation.
ER stress is a key event in ALD, contributing to steatosis and
liver injury [93]. The ER plays an essential role in the integration of
multiple metabolic signals and the maintenance of cell home-
ostasis, particularly protein synthesis and folding. Under stress
conditions induced by protein misfolding, the ER triggers an
adaptive response called uncoupled protein response (UPR). To
resolve ER stress, UPR promotes a decrease in protein synthesis,
and an increase in protein degradation and chaperone production
for protein folding. Alcohol-induced perturbation in methionine
metabolism is believed to contribute to ER stress, as betaine
supplementation prevented ER stress, steatosis and liver injury
in mice fed alcohol [94]. Moreover, tauroursodeoxycholic acid
(TUDCA), a chemical chaperone that prevents ER stress [95],
restores the mGSH pool in alcohol fed rats [59] and ameliorates
alcohol-induced ER stress [74]. Emerging evidence has demon-
strated that StARD1 is a previously unrecognized target of the UPR
and ER stress signaling. Indeed, tunicamycin, an ER stress trigger,
induces the expression of StARD1 in isolated hepatocytes and this
effect is prevented by TUDCA treatment [74]. Moreover, mice fed a
high cholesterol diet (HC) exhibited increased expression of
StARD1. However, HC feeding downregulates the expression of
SREBP-2-regulated target genes, including hydroxymethylglutaryl
Co-A reductase, demonstrating that StARD1 is and an ER stress but
not SREBP-2 regulated gene. In contrast to StARD1, the role of ER
stress in the regulation of StART family members has been limited
to StARD5 [96,97], with conﬂicting results reported for StARD4
[96,98]. As the UPR comprises three transducers, namely inositol
requiring (IRE) 1α, PKR-like ER kinase (PERK), and activating
transcription factor (ATF) 6α, which are controlled by the master
regulator glucose-regulated protein 78 (GRP78 also known as BiP),
further work is needed to examine the relative contribution of IRE-
1α, PERK and ATF6α arms in the regulation of StARD1 (Fig. 2).
Besides ER stress, StARD1 activation is regulated at the transcrip-
tional and post-translational levels. In murine steroidogenic cells
StARD1 activity and subsequent steroidogenesis increases upon
StARD1 phosphorylation at serine residues [99,100]. Whether ore upregulation of StARD1 is the onset of ER stress by alcohol. Alcohol-mediated
ctivation of transcription factor SREBP-2 that regulate de novo cholesterol synthesis
ional regulation of StARD1. Whether ASMase-induced ceramide generation induces
ides the regulation of StARD1 at the transcriptional level, phosphorylation events
cholesterol. Further work is required to determine the relative contribution of the
kinases that phosphorylate StARD1.
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cholesterol homeostasis remains to be explored. If so, then the
identiﬁcation of putative kinases that phosphorylate and activate
StARD1 may be of potential relevance in ALD. Overall, these ﬁndings
indicate that the upregulation of StARD1 by alcohol-induced ER stress
determines the accumulation of cholesterol in the mitochondrial
inner membrane.Acid sphingomyelinase regulates ER stress in ALD
Acid sphingomyelinase (ASMase) is a speciﬁc mechanism that
generates ceramide, the prototype sphingolipid that in addition to
its critical structural function in membrane bilayers, it regulates
apoptosis, cellular senescence, stress response, inﬂammation and
metabolism [101–103]. Sphingomyelin hydrolysis by ASMase gen-
erates a speciﬁc pool of ceramide that mediates TNF-induced
hepatocellular injury and liver failure [104,105]. ASMase also
regulates Fas-mediated liver failure [106] and is a critical apoptotic
enzyme mediating radiation and chemotherapy induced cell death
[102]. Besides its proapoptotic function, ASMase regulates liver
ﬁbrosis by controlling hepatic stellate cell transdifferentiation into
a myoﬁbroblast phenotype and by regulating cathepsin activation
[107,108]. Recent ﬁndings have reported that sortilin deletion, a
member of the vacuolar protein sorting 10 protein (VPS10P)-
domain receptor family which functions both as a co-receptor
and as a trafﬁcking molecule, ameliorates HFD-mediated meta-
bolic disruption by inhibiting ASMase [109]. Moreover, alcohol
feeding increases ASMase expression and activity in experimental
models and patients with acute AH [74,110]. Recent ﬁndings have
shown that ASMase is required for alcohol-induced ER stress [74].
The link of ASMase and ER stress induction in the context of ALD is
of interest. Alcohol feeding induces hyperhomocysteinemia, which
is thought to contribute to ER stress [93,94]. However, ASMase null
mice fed alcohol do not exhibit ER stress despite increased
homocysteine (Hcy) to levels similar to those seen in wild
littermates and were resistant to alcohol-induced steatosis, sus-
ceptibility to LPS and concanavalin A-mediated liver injury and
mitochondrial cholesterol accumulation [74]. However, tunicamy-
cin induces ER stress in ASMase null mice, indicating that the
resistance of ASMase null mice to alcohol-induced ER stress is not
due to an inherent defect in the ER stress response. The ﬁndings
that Hcy requires ASMase to induce ER stress are consistent with
recent observations that ASMase ablation prevents Hcy-induced
glomerular injury in mice deﬁcient in cystathionine β-synthase
mice, a genetic model of hyperhomocysteinemia characterized by
increased plasma Hcy levels [111]. Moreover, ASMase silencing
prevents Hcy-induced ceramide generation, indicating that AS-
Mase activation by Hcy is a major pathway of glomerular ceramide
generation. Furthermore, mice fed a chow diet supplemented with
Hcy exhibit increased plasma Hcy levels but no pathophysiologic
changes or ER stress [112]. Hence, these data suggest that Hcy at
pathophysiological concentrations plays a minor role in ER stress
and steatosis and that the association between Hcy and ER stress
are not causally related. While these ﬁndings dissociate Hcy from
ER stress, they also suggest that ASMase functions as an ER stress
trigger. In line with this possibility, incubation of HepG2 cells with
exogenous ASMase but not NSMase increases the expression of ER
stress markers and this event is accompanied by disruption of ER
Ca2þ homeostasis in response to thapsigargin [74], in agreement
with previous data using cell permeable ceramide C2 [113].
Although, this outcome supports the concept that altered lipid
composition in the ER regulates ER Ca2þ homeostasis and sub-
sequent ER stress susceptibility [114,115], it remains to be estab-
lished whether ASMase activation modulates SERCA activity in the
ER by disrupting ER membrane physical properties. Consistentwith these ﬁndings, ASMase null mice are refractory to alcohol-
mediated cholesterol accumulation and subsequent mGSH deple-
tion due to the lack of ER stress-mediated StARD1 expression [74].
Maintenance of mGSH homeostasis is associated with resistance to
LPS and ConA-mediated liver damage in the absence of ASMase. In
addition to the regulation of mitochondrial function, ASMase
regulates other cell death pathways, including the lysosomal
membrane permeabilization (LMP) as well as autophagy [116].
The ability of ASMase in promoting LMP is due to the decrease in
lysosomal cholesterol levels secondary to the hydrolysis of lyso-
somal sphingomyelin pool by ASMase. To explore the potential
relevance of the ASMase–ER stress–StARD1 pathway in ALD,
ASMase inhibition by amitriptyline protected against alcohol-
induced steatosis, ER stress and susceptibility to LPS/ConA-in-
duced liver injury in wild type mice fed alcohol. Overall, these data
indicate that ASMase is critical for alcohol-induced ER stress, and
provide a rationale for further clinical investigation in ALD point-
ing to ASMase as a potential relevant target in the treatment of
ALD by preventing alcohol-induced ER stress and subsequent
downstream events.Conclusions and future directions
Mitochondria are unique organelles responsible for life sustain-
ing reactions and cell death pathways. They are the main produ-
cers of ROS/RNS species within MCR and are targets of alcohol
toxicity. Essential for the metabolism of alcohol, mitochondria
regenerate NADþ from NADH to oxidize alcohol, a process that
generates ROS as subproducts. Cumulative evidence both in
patients and in experimental models of ALD, indicate mitochon-
drial abnormalities at the morphological and functional levels
caused by alcohol. Given the critical role of mGSH in controlling
hepatocellular survival in the face of inﬂammation and oxidative
stress, its depletion caused by alcohol is thought to be of
signiﬁcance in ALD. As cholesterol accumulation by alcohol down-
regulates mGSH, a better understanding of the cell biology and
mechanisms responsible for cholesterol upregulation and trafﬁck-
ing to mitochondrial membranes, including ER stress, may open
up novel avenues for intervention and treatment. In this regard,
emerging data indicate that alcohol-induced ER stress is an
important mechanism leading to mitochondrial cholesterol accu-
mulation and hence mGSH depletion. The onset of ER stress
appears to be independent of hyperhomocysteinemia and requires
ASMase which upregulates the expression of the mitochondrial
cholesterol transporter StARD1. Hence, targeting ASMase may
constitute a novel approach in the treatment of ALD. The current
evidence in experimental models may further stimulate clinical
investigations on the potential of ASMase inhibition in patients
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